ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

Simone Replaces Levine As Cancer Policy Board Chairman

April 19, 2002